Hyaluronic acid inhalation (Actelion Pharmaceuticals)

透明质酸吸入剂 (Actelion Pharmaceuticals)

Report date: 2025/03/27 10:41:41

Base Information

Drug NameHyaluronic acid inhalation (Actelion Pharmaceuticals)
Drug Alias NameHyaluronic acid inhalation - Actelion PharmaceuticalsHyaluronan inhalation - Actelion PharmaceuticalsETX-100CTX-100
ClassificationSmall molecules > Carbohydrate
Mechanisms of ActionHyaluronic acid modulators
TargetsHyaluronic acid
Therapy Area/Indicationsalpha 1-Antitrypsin Deficiency
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCotherix Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCotherix Inc
Active IndicationsN/A
Inactive Indicationsalpha 1-Antitrypsin Deficiency

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG